Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
Not yet recruiting · NCT06932094 · Registry updated 2025-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2025-04-23 | NCT06932094 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |